Brief: Australian Clinical Labs Says Reviewing Healius' Target's Statement
05/05/2023 02:33
May 5 (Reuters) - Australian Clinical Labs Ltd ACL.AX :
* REVIEWING & CONSIDERING INFORMATION CONTAINED IN HEALIUS
TARGET’S STATEMENT WITH ITS ADVISERS
* ACL'S OFFER FOR HEALIUS IS OPEN FOR ACCEPTANCE UNTIL
7.00PM
(SYDNEY TIME) ON 29 SEPT
* NOTES HEALIUS IDENTIFIES NUMBER OF CONDITIONS OF OFFER
THAT IT
CONSIDERS ARE NOT LIKELY TO BE SATISFIED
Source text for Eikon: ID:nASX6126vn
Further company coverage: ACL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Healius
See all newsAustralia's Healius rises on sale of unit Agilex; Jefferies lifts PT
Brief: Healius To Sell Agilex Biolabs To Novotech
Australia's Healius rises on sale of unit Agilex Biolabs to Novotech Health
Brief: Healius Requests Trading Halt
Brief: Healius Expects To Achieve T27 Target Of Mid-To-High Single-Digit EBIT Margins By Dec 2028